Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, and Cancer Cells and Metastasis.
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display
Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity
NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses